Abstract
Blood steroid profile is a recently introduced test in India that is commercially available through a few diagnostic laboratories. In adult women, ACTH-stimulated steroid panel helps to differentiate polycystic ovary syndrome (PCOS) from nonclassical forms of CAH. However, the interpretation of ACTH-stimulated steroid panels is often impeded by the limited availability of reference ranges. Here, we report the adrenal steroid levels after stimulation with Acton Prolongatum in Asian Indian women of reproductive age. This prospective study was conducted at a tertiary health care center in the Southern part of India. Apparently healthy women in the reproductive age group with regular menstrual cycles (21–35 days) at least over the last 6 months were included. All participants received intramuscular Acton Prolongatum® (Pfizer) in the morning hours during the follicular phase and the steroid profile was analyzed by liquid chromatography–tandem mass spectrometry in a blood sample collected 60-min later. The study included 32 apparently healthy women. The mean age of the study population was 22.19 ± 4.36 years. None of the participants experienced any adverse events during the procedure. The median (range) serum cortisol, 17α-hydroxyprogesterone, 11-deoxycortisol, and corticosterone were 22.65 (14.3–37.21) μg/dl, 99.72 (47.21–344.71) ng/dl, 287.2 (74.41–530.61) ng/dl and 728.04 (118.74–1708.2) respectively. In conclusion, this is the first report of the response of adrenal steroids measured by LC–MS/MS at 60 min after Acton Prolongatum in Asian Indian women of the reproductive age group. However, further larger studies are warranted to establish more robust ACTH-stimulated reference ranges for steroid profile in Indian women.
References
Sarathi V, Atluri S, Pradeep TVS, Rallapalli SS, Rakesh CV, Sunanda T, et al. Utility of a commercially available blood steroid profile in endocrine practice. Indian J Endocrinol Metab. 2019;23:97–101.
Karlekar MP, Sarathi V, Lila A, Rai K, Arya S, Bhandare VV, et al. Expanding genetic spectrum and discriminatory role of steroid profiling by LC-MS/MS in 11β-hydroxylase deficiency. Clin Endocrinol (Oxf). 2021;94:533–43.
Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:4043–88.
Holst JP, Soldin SJ, Tractenberg RE, Guo T, Kundra P, Verbalis JG, et al. Use of steroid profiles in determining the cause of adrenal insufficiency. Steroids. 2007;72:71–84.
Kulle AE, Riepe FG, Hedderich J, Sippell WG, Schmitz J, Niermeyer L, et al. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers. Eur J Endocrinol. 2015;173:517–24.
Lindner JM, Suhr AC, Grimm SH, Möhnle P, Vogeser M, Briegel J. The dynamics of a serum steroid profile after stimulation with intravenous ACTH. J Pharm Biomed Anal. 2018;151:159–63.
Nair A, Jayakumari C, George GS, Jabbar PK, Das DV, Jessy SJ, et al. Long-acting porcine sequence ACTH in the diagnosis of adrenal insufficiency. Eur J Endocrinol. 2019;181:639–45.
Grassi G, Morelli V, Ceriotti F, Polledri E, Fustinoni S, D’Agostino S, et al. Minding the gap between cortisol levels measured with second-generation assays and current diagnostic thresholds for the diagnosis of adrenal insufficiency: a single-center experience. Hormones (Athens). 2020;19:425–31.
Javorsky BR, Raff H, Carroll TB, Algeciras-Schimnich A, Singh RJ, Colón-Franco JM, et al. New cutoffs for the biochemical diagnosis of adrenal insufficiency after ACTH stimulation using specific cortisol assays. J Endocr Soc. 2021;5(4):bvab022. https://doi.org/10.1210/jendso/bvab022.
Kline GA, Buse J, Krause RD. Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay. Clin Biochem. 2017;50:475–80.
Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(11):4043–88.
Costa-Barbosa FA, Carvalho VM, Oliveira KC, Vieira JGH, Kater CE. Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects. Clin Endocrinol (Oxf). 2021;95:677–85.
Costa-Barbosa FA, Tonetto-Fernandes VF, Carvalho VM, Nakamura OH, Moura V, Bachega TA, et al. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency. Clin Endocrinol (Oxf). 2010;73(6):700–6.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sarathi, V., Reddy, A., Tirupati, S. et al. Acton-Prolongatum Stimulated Blood Steroid Profile in Apparently Healthy Asian Indian Women of Reproductive-Age Group. Ind J Clin Biochem 38, 541–544 (2023). https://doi.org/10.1007/s12291-022-01039-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-022-01039-7